MIT researchers found that benzo(a)pyrene plays a small part—about 11%—in the global risk of developing polycyclic aromatic hydrocarbons (PAHs)-associated cancer.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe